Washington, DC, United States of America

Christopher Heier

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Children's National Medical Center. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Heier: Innovator in Muscular Disorder Treatments

Introduction

Christopher Heier is a notable inventor based in Washington, DC, who has made significant contributions to the field of medical treatments. His work primarily focuses on developing innovative solutions for muscular disorders and related conditions.

Latest Patents

Heier holds a patent for "Compositions and methods for treating and preventing muscular disorders and dystrophies, steroid side effects, and inflammation." This patent describes compositions that include an antisense RNA sequence that is substantially complementary to an miRNA. The pharmaceutical compositions may also contain an anti-inflammatory corticosteroid. The methods outlined in the patent aim to treat or prevent inflammation, steroid side effects, or muscle diseases using these compositions.

Career Highlights

Christopher Heier is affiliated with the Children's National Medical Center, where he applies his expertise in medical research and innovation. His work has the potential to impact the treatment of various muscular disorders significantly.

Collaborations

He collaborates with Alyson Fiorillo, contributing to advancements in their shared field of research.

Conclusion

Christopher Heier's innovative work in developing treatments for muscular disorders showcases his commitment to improving patient outcomes. His contributions through his patent and collaboration with colleagues highlight the importance of research in medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…